
Jaxin Ross Erickson
Counselor/Therapist
3321 W KENNEWICK AVE STE 150 KENNEWICK WA, 99336About
Jaxin Erickson is a counselor in KENNEWICK, WA. Jaxin evaluates patients using many different procedures, in order to determine what treatments must be carried out in order to properly assess their symptoms. Counselors provide consultation for each patient and their families.
Provider Details
Jaxin Ross Erickson's Practice location
Jaxin Ross Erickson's reviews
Write ReviewRecommended Articles
- Effects of Genital HPV on Newborn Babies
HPV, which is also known as the Human papilloma virus, is a group of viruses that affects the skin and the moist membranes lining the body. HPV usually affects the cervix, the anus, or the mouth and the throat. There are about 100 types of HPV, from which 30 types affect the genital area. The HPV...
- What Is a Lower Back Pain with Sciatica?
Lower back pain is a common problem experienced by most people at some point during their lifetime. There are several causes for lower back pain with sciatica, and the intensity of pain can range from dull to quite severe. Men and women are equally affected by this condition. Most cases of back pain...
- Reasons Why You Need Occupational Therapy
Our days go by with daily occupations. These occupations represent who we really are in life. Different occupations performed daily may include different roles like being a husband, wife, parent, child, football player, tennis player, an actor, musician, doctor, firefighter, etc. Our occupations...
- How is Testicular Cancer Diagnosed?
Roughly 10,000 men are estimated to be diagnosed with cancer of the testes each year, out of which roughly 400 are expected to succumb to the disease according to statistical cancer projections. If the prevalence of testicular cancer compared to the overall population appears on the lower side, the...
- Exposure to DDT Increases the Risk of Testicular Cancer
Men exposed to the remnants of DDT, a once popular pesticide, have an increased risk of testicular cancer, according to a study published in Journal of the National Cancer Institute. The study shows that men who have high levels of DDT by-product, dichlorodiphenyldichloroethylene (DDE), have a 1.7...
- FDA Approves Baricitinib for Adults with Active Rheumatoid Arthritis
On June 1st of 2018, the US Food and Drug Administration (FDA) approved Olumiant (Baricitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA) who have had an inadequate response or intolerance to one or more TNF inhibitor therapies. “We are pleased to provide RA...